1 result for "REZUBIO PHARMACEUTICALS CO., LTD"
Add this URL to any RSS reader. Updated daily.
Anticholinergic Agents Patent US12606549B2, Rezubio Pharma
The USPTO granted US Patent 12606549B2 to Rezubio Pharmaceuticals Co., Ltd covering muscarinic acetylcholine receptor antagonist compounds (including M3 antagonists) and pharmaceutical compositions for treating hyperhidrosis. The patent contains 19 claims and names Yusheng Xiong and Hongping Guan as inventors.
Routine
Rule
Intellectual Property
Get alerts for "REZUBIO PHARMACEUTICALS CO., LTD"
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Browse Categories
Agriculture & Food Safety
73
AI Regulation
3
Banking & Finance
412
Consumer Protection
89
Courts & Legal
411
Data Privacy & Cybersecurity
90
Defense & National Security
53
Education
55
Energy
100
Environment
152
Gaming
2
Government & Legislation
430
Healthcare
15
Healthcare & Life Sciences
375
Immigration
10
Insurance
76
Labor & Employment
134
Pharma & Drug Safety
21
Professional Licensing
8
Real Estate & Housing
78
Securities & Markets
154
Tax
78
Telecom & Technology
47
Trade & Sanctions
141
Transportation
91
Get alerts for "REZUBIO PHARMACEUTICALS CO., LTD"
We'll email you when new changes match "REZUBIO PHARMACEUTICALS CO., LTD".
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.
You're subscribed!